PD-027Efficacy of retreatment with anti-EGFRs in metastatic colorectal cancer is not predictable by clinical factors related to prior lines of therapy: a multi-institutional analysis. (2nd July 2019) - Rossini, D; Pagani, F; Pellino, A; Dell'Aquila, E; Liscia, N; Bensi, M; Germani, M; Masi, G; Moretto, R; Santini, D; Salvatore, L; Scartozzi, M; et al.